Aligos Therapeutics Inc
NASDAQ:ALGS
Aligos Therapeutics Inc
NASDAQ:ALGS
Price:
5.6
USD
8.11%
Market Closed
Market Cap:
$34.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
US |
|
Nephros Inc
NASDAQ:NEPH
|
US |
|
D
|
Dohome PCL
SET:DOHOME
|
TH |
|
ENDRA Life Sciences Inc
NASDAQ:NDRA
|
US |
|
Itron Inc
NASDAQ:ITRI
|
US |
|
Ryan Specialty Group Holdings Inc
NYSE:RYAN
|
US |
|
E
|
EDP Renovaveis SA
ELI:EDPR
|
ES |
Wall St Price Targets
ALGS Price Targets Summary
Aligos Therapeutics Inc
Aligos Therapeutics Inc
Wall Street analysts forecast ALGS stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ALGS is 39.27 USD with a low forecast of 20.2 USD and a high forecast of 52.5 USD.
Lowest Forecast
Price Target
20.2
USD
261% Upside
Average Forecast
Price Target
39.27
USD
601% Upside
Highest Forecast
Price Target
52.5
USD
838% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALGS's stock price target?
Price Target
39.27
USD
39.27
USD
According to Wall Street analysts, the average 1-year price target for ALGS is 39.27 USD with a low forecast of 20.2 USD and a high forecast of 52.5 USD.
What is the Revenue forecast for Aligos Therapeutics Inc?
Projected CAGR
118%
118%
The compound annual growth rate for Revenue over the next 8 years is 118%.
